Back to Search
Start Over
Quercetin and indole-3-carbinol inhibit extracellular matrix expression in human primary uterine leiomyoma cells.
- Source :
-
Reproductive BioMedicine Online (Elsevier Science) . Apr2020, Vol. 40 Issue 4, p593-602. 10p. - Publication Year :
- 2020
-
Abstract
- What is the effect of quercetin and indole-3-carbinol (I3C) on extracellular matrix expression, cell migration and proliferation in human myometrial and uterine leiomyoma cells. Myometrial and leiomyoma cells were treated with quercetin or I3C at different concentrations (10 µg/ml; 50 µg/ml; 100 µg/ml; and 250 µg/ml) for 48 h to measure mRNA and protein expressions of extracellular matrix (collagen 1A1, fibronectin and versican), as well as cell migration and the proliferation rate. Quercetin decreased mRNA levels of collagen 1A1 in myometrial (P < 0.0001) and leiomyoma cells (P < 0.0001). Quercetin reduced mRNA and protein levels of fibronectin in myometrial cells (P < 0.05) and fibronectin protein in leiomyoma cells (P < 0.05). I3C reduced collagen 1A1 mRNA levels in myometrial (P < 0.05) and leiomyoma cells at higher dose (P < 0.05). The protein levels of fibronectin were also reduced in both myometrial and leiomyoma cells with highest dose of I3C (P < 0.05), although mRNA levels were not affected in leiomyoma cells. Neither quercetin nor I3C treatment altered versican mRNA levels in both cell types. A significant reduction of the migration of both myometrial and leiomyoma cells in response to quercetin was observed (P < 0.05) and I3C (P < 0.05 for myometrial and P < 0.01 for leiomyoma cells) treatment. Both quercetin and I3C significantly reduced myometrial cell proliferation (P < 0.05). The in-vitro anti-fibrotic, anti-migratory and anti-proliferative effects of quercetin and I3C form the scientific basis for developing new therapeutic, preventive agents, or both, for uterine leiomyomas. [ABSTRACT FROM AUTHOR]
Details
- Language :
- English
- ISSN :
- 14726483
- Volume :
- 40
- Issue :
- 4
- Database :
- Academic Search Index
- Journal :
- Reproductive BioMedicine Online (Elsevier Science)
- Publication Type :
- Academic Journal
- Accession number :
- 142912232
- Full Text :
- https://doi.org/10.1016/j.rbmo.2020.01.006